Cargando…
Caloric restriction in C57BL/6J mice mimics therapeutic fasting in humans
BACKGROUND: Caloric restriction (CR) has long been recognized as a dietary therapy that improves health and increases longevity. Little is known about the persistent effects of CR on plasma biomarkers (glucose, ketone bodies, and lipids) following re-feeding in mice. It is also unclear how these bio...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1513228/ https://www.ncbi.nlm.nih.gov/pubmed/16709251 http://dx.doi.org/10.1186/1476-511X-5-13 |
_version_ | 1782128462547386368 |
---|---|
author | Mahoney, Lisa B Denny, Christine A Seyfried, Thomas N |
author_facet | Mahoney, Lisa B Denny, Christine A Seyfried, Thomas N |
author_sort | Mahoney, Lisa B |
collection | PubMed |
description | BACKGROUND: Caloric restriction (CR) has long been recognized as a dietary therapy that improves health and increases longevity. Little is known about the persistent effects of CR on plasma biomarkers (glucose, ketone bodies, and lipids) following re-feeding in mice. It is also unclear how these biomarker changes in calorically restricted mice relate to those observed previously in calorically restricted humans. RESULTS: Three groups of individually housed adult female C57BL/6J (B6) mice (n = 4/group) were fed a standard rodent chow diet either: (1) unrestricted (UR); (2) restricted for three weeks to reduce body weight by approximately 15–20% (R); or (3) restricted for three weeks and then re-fed unrestricted (ad libitum) for an additional three weeks (R-RF). Body weight and food intake were measured throughout the study, while plasma lipids and levels of glucose and ketone bodies (β-hydroxybutyrate) were measured at the termination of the study. Plasma glucose, phosphatidylcholine, cholesterol, and triglycerides were significantly lower in the R mice than in the UR mice. In contrast, plasma fatty acids and β-hydroxybutyrate were significantly higher in the R mice than in the UR mice. CR had no effect on plasma phosphatidylinositol levels. While body weight and plasma lipids of the R-RF mice returned to unrestricted levels upon re-feeding, food intake and glucose levels remained significantly lower than those prior to the initiation of CR. CONCLUSION: CR establishes a new homeostatic state in B6 mice that persists for at least three weeks following ad libitum re-feeding. Moreover, the plasma biomarker changes observed in B6 mice during CR mimic those reported in humans on very low calorie diets or during therapeutic fasting. |
format | Text |
id | pubmed-1513228 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-15132282006-07-20 Caloric restriction in C57BL/6J mice mimics therapeutic fasting in humans Mahoney, Lisa B Denny, Christine A Seyfried, Thomas N Lipids Health Dis Research BACKGROUND: Caloric restriction (CR) has long been recognized as a dietary therapy that improves health and increases longevity. Little is known about the persistent effects of CR on plasma biomarkers (glucose, ketone bodies, and lipids) following re-feeding in mice. It is also unclear how these biomarker changes in calorically restricted mice relate to those observed previously in calorically restricted humans. RESULTS: Three groups of individually housed adult female C57BL/6J (B6) mice (n = 4/group) were fed a standard rodent chow diet either: (1) unrestricted (UR); (2) restricted for three weeks to reduce body weight by approximately 15–20% (R); or (3) restricted for three weeks and then re-fed unrestricted (ad libitum) for an additional three weeks (R-RF). Body weight and food intake were measured throughout the study, while plasma lipids and levels of glucose and ketone bodies (β-hydroxybutyrate) were measured at the termination of the study. Plasma glucose, phosphatidylcholine, cholesterol, and triglycerides were significantly lower in the R mice than in the UR mice. In contrast, plasma fatty acids and β-hydroxybutyrate were significantly higher in the R mice than in the UR mice. CR had no effect on plasma phosphatidylinositol levels. While body weight and plasma lipids of the R-RF mice returned to unrestricted levels upon re-feeding, food intake and glucose levels remained significantly lower than those prior to the initiation of CR. CONCLUSION: CR establishes a new homeostatic state in B6 mice that persists for at least three weeks following ad libitum re-feeding. Moreover, the plasma biomarker changes observed in B6 mice during CR mimic those reported in humans on very low calorie diets or during therapeutic fasting. BioMed Central 2006-05-18 /pmc/articles/PMC1513228/ /pubmed/16709251 http://dx.doi.org/10.1186/1476-511X-5-13 Text en Copyright © 2006 Mahoney et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Mahoney, Lisa B Denny, Christine A Seyfried, Thomas N Caloric restriction in C57BL/6J mice mimics therapeutic fasting in humans |
title | Caloric restriction in C57BL/6J mice mimics therapeutic fasting in humans |
title_full | Caloric restriction in C57BL/6J mice mimics therapeutic fasting in humans |
title_fullStr | Caloric restriction in C57BL/6J mice mimics therapeutic fasting in humans |
title_full_unstemmed | Caloric restriction in C57BL/6J mice mimics therapeutic fasting in humans |
title_short | Caloric restriction in C57BL/6J mice mimics therapeutic fasting in humans |
title_sort | caloric restriction in c57bl/6j mice mimics therapeutic fasting in humans |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1513228/ https://www.ncbi.nlm.nih.gov/pubmed/16709251 http://dx.doi.org/10.1186/1476-511X-5-13 |
work_keys_str_mv | AT mahoneylisab caloricrestrictioninc57bl6jmicemimicstherapeuticfastinginhumans AT dennychristinea caloricrestrictioninc57bl6jmicemimicstherapeuticfastinginhumans AT seyfriedthomasn caloricrestrictioninc57bl6jmicemimicstherapeuticfastinginhumans |